• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

ERDV:GR

22.3500 EUR 0.0500 0.22%

As of 15:45:07 ET on 07/24/2014.

Snapshot for BlackRock Global Funds - World Healthscience Fund (ERDV)

Open: 22.4900 High - Low: 22.8300 - 22.1700 Primary Exchange: Berlin
Volume: 25 52-Week Range: 17.6300 - 22.8300 Beta vs NDWUHC: 0.8840

ETF Chart for ERDV

No chart data available.
  • ERDV:GR 22.8300
  • 1D
  • 1M
  • 1Y
22.4000
Interactive ERDV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ERDV

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 2001-04-06 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN
Web Site: www.blackrockinternational.com

Fundamentals for ERDV

NAV (on 2014-07-24) 22.5500
Assets (M) (on 2014-06-30) 2,374.0970
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -0.89
Average 52-Week % Premium -0.8788
Fund Leveraged N

Dividends for ERDV

No dividends reported

Performance for ERDV

1-Month +2.05% 1-Year +21.73%
3-Month +10.59% 3-Year +21.05%
Year To Date +14.09% 5-Year +19.18%
Expense Ratio 1.84

Top Fund Holdings for ERDV

Filing Date: 05/30/2014
Name Position Value % of Total
Johnson & Johnson 1,132,500 114,903,450 5.053%
Merck & Co Inc 1,682,900 97,372,594 4.282%
Novartis AG 984,800 88,460,697 3.890%
Roche Holding AG 273,300 80,557,693 3.543%
AbbVie Inc 1,469,500 79,837,935 3.511%
Biogen Idec Inc 223,700 71,443,069 3.142%
Pfizer Inc 2,374,200 70,347,546 3.094%
Bayer AG 459,000 66,453,449 2.923%
Alexion Pharmaceuticals Inc 390,168 64,892,742 2.854%
Celgene Corp 748,108 57,241,484 2.517%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil